Mechanism of enhanced production of triterpenoids in algal-fungal consortium

Bioprocess Biosyst Eng. 2022 Oct;45(10):1625-1633. doi: 10.1007/s00449-022-02768-y. Epub 2022 Aug 13.

Abstract

Chlorella pyrenoidosa-Ganoderma lucidum symbiotic systems were constructed. The mechanism of enhanced production of triterpenoids in algal-fungal consortium by comparing the contents of triterpenoids in individual fungal systems and algal-fungal consortium systems was investigated. The production of triterpenoids in C. pyrenoidosa-G. lucidum consortium increased significantly (P < 0.05). The categories and relative abundances of metabolites in the individual systems and algal-fungal systems were measured and analyzed by metabonomic tests. There were 57 significant different metabolites (VIP > 1 and P < 0.05) including 12 downregulated metabolites and 45 upregulated metabolites were obtained. The significant enriched metabolic pathways (VIP > 1 and P < 0.05) of citrate cycle (TCA cycle), tyrosine metabolism, glycolysis, and terpenoid backbone biosynthesis in algal-fungal consortium were obtained. The relative abundances of important precursors of triterpenoids including mevalonic acid, lanosterol, and hydroquinone were 1.4 times, 1.7 times, and 2 times, respectively, in algal-fungal consortium than that in the individual fungal systems. The presence of C. pyrenoidosa in algal-fungal consortium promoted the biosynthesis of triterpenoids in G. lucidum.

Keywords: Algal–fungal consortium; Chlorella pyrenoidosa; Ganoderma lucidum; Triterpenoids.

MeSH terms

  • Chlorella* / metabolism
  • Citrates / metabolism
  • Hydroquinones / metabolism
  • Lanosterol / metabolism
  • Mevalonic Acid / metabolism
  • Reishi* / metabolism
  • Triterpenes* / metabolism
  • Tyrosine / metabolism

Substances

  • Citrates
  • Hydroquinones
  • Triterpenes
  • Lanosterol
  • Tyrosine
  • Mevalonic Acid